Andrew James King, Chief Scientific Officer at CHINOOK THERAPEUTICS, INC. (KDNY), sold 6,488 shares at $24.68 ($160K) on 2023-01-31, disclosed to the SEC on 2023-02-02.
Open-market sale of $160k KDNY by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.68 | 3,244 | $80K | 50.0% |
| 2 | $24.68 | 3,244 | $80K | 50.0% |
| Total | $24.68 avg | 6,488 | $160K | 100% |
| Filing → |
| KDNY | SELL | 2023-02-15 | $57K | — | Filing → |
| KDNY | SELL | 2023-01-04 | $258K | — | Filing → |
| KDNY | SELL | 2022-10-11 | $140K | — | Filing → |